رسالة جامعية

Burden of Chronic Hepatitis B in Alberta, Canada

التفاصيل البيبلوغرافية
العنوان: Burden of Chronic Hepatitis B in Alberta, Canada
المؤلفون: Kochaksaraei, Golasa Samadi
المساهمون: Shaheen, Abdel-Aziz, Coffin, Carla S, Barkema, Herman, Seow, Cynthia
بيانات النشر: Graduate Studies
University of Calgary
سنة النشر: 2023
المجموعة: PRISM - University of Calgary Digital Repository
مصطلحات موضوعية: Hepatitis B, Epidemiology, Incidence, Prevalence, Burden of Disease, Survival, Natural History, Prenatal Transmission, Pregnancy, Women of Childbearng Age, Postpartum, Tenofovir Disoproxil Fumarate, Linkage to Care
الوصف: Limited recent data exist on chronic hepatitis B (CHB) burden in the North American general population, especially among women of childbearing age (WoCBA). Despite evidence supporting peripartum tenofovir disoproxil fumarate (TDF) prophylaxis in reducing mother-to-child transmission (MTCT), long-term outcomes of untreated and TDF-treated CHB pregnant women are understudied. We aimed to identify the CHB burden in Alberta, Canada, among all ages and WoCBA (18-49 years) and assess clinical outcomes in a multiethnic cohort of CHB patients during pregnancy and postpartum. We retrospectively searched Alberta Analytics administrative databases to describe CHB epidemiology and natural history in all ages and WoCBA between fiscal years 2012-2020. We also examined care linkage among hepatitis B surface antigen (HBsAg)-positive pregnant women during the same period. Furthermore, we collected real-world clinical data during pregnancy and postpartum in women with CHB between 2011-2019. From 2015-2020, the CHB incidence declined to 13.4/100,000 (from 36.4/100,000) for all ages and 18.2/100,000 (from 52.6/100,000) for WoCBA. However, prevalence increased to 210.3/100,000 (from 98.9/100,000) for all ages and 248.6/100,000 (from 131.7/100,000) for WoCBA. CHB patients had lower survival rates than age/sex-matched Canadians (standardized mortality ratios of 3.9 and 5.7 for all ages and WoCBA, respectively). Among 1,927 women (2,436 HBsAg-positive pregnancies) between 2012-2020, 27.6% had recommended hepatitis B-directed assessment during pregnancy and 66.4% of those eligible for antiviral prophylaxis received treatment. In 341 women (446 pregnancies) followed for a median of 33 months postpartum, 19% received TDF (64/341, 53/64 for MTCT prevention). In HBeAg-positive patients (65/341), alanine aminotransferase (ALT) flares were more common, especially in those who stopped TDF postpartum. HBsAg clearance occurred in 2.6% (9/341, 2/9 TDF treated) at a median of 30 months, and 37% (24/65) of hepatitis B e antigen (HBeAg)-positive ...
نوع الوثيقة: doctoral or postdoctoral thesis
وصف الملف: application/pdf
اللغة: English
العلاقة: Kochaksaraei, G. S. (2023). Burden of chronic hepatitis B in Alberta, Canada (Doctoral thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.caTest.; https://hdl.handle.net/1880/117379Test
الإتاحة: https://hdl.handle.net/1880/117379Test
حقوق: University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.
رقم الانضمام: edsbas.BBC1BB01
قاعدة البيانات: BASE